genOway signs exclusive US distribution deal with Taconic Biosciences for humanized models
Bitget2026/09/23 16:02- genOway signed an exclusive U.S. distribution agreement with Taconic Biosciences to expand sales of its humanized preclinical models.
- Taconic will resell products purchased from genOway, making each Taconic sale incremental revenue for genOway.
- Deal terms aim to keep profitability close to direct sales, supporting near-term earnings leverage.
- Management flagged potential to double U.S. activity, its largest market with more than 50% of sales.
- Partnership adds nationwide U.S. commercial coverage through Taconic’s sales network, accelerating penetration of a market estimated above USD 1 billion annually.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Silver Price Forecast: XAG/USD trades flat around $53 ahead of US inflation data
Swiss Franc holds ground as US Dollar consolidates ahead of CPI inflation data
Net profit surges fivefold but masks decline in core business; crypto mining companies' shift to AI poses hidden risks
Marathon Holdings' Q3 net profit reached $632 million, up 413% year-on-year. However, its mining revenue declined by 35%. The company relied on selling 13,500 BTC to pay off debts and is now betting on AI infrastructure, increasing the risk of an imbalanced profit structure.
Lithium-For-Earth Raises KRW 1.32 Billion in Private Placement
Crypto prices
More
